Publications dans lesquelles il/elle collabore avec Juan J. Gómez Doblas (14)

2023

  1. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  2. Treatment of hypertriglyceridaemia with icosapent ethyl in patients with high/very high cardiovascular risk. Consensus document of the Sociedad Española de Cardiología [Spanish Society of Cardiology] and the Sociedad Española de Diabetes [Spanish Diabetes Society]

    Endocrinologia, Diabetes y Nutricion, Vol. 70, pp. 51-62

2022

  1. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice

    Revista Española de Cardiología (English Edition), Vol. 75, Núm. 5, pp. 364-369

  2. Major Adverse Cardiovascular Events in Coronary Type 2 Diabetic Patients: Identification of Associated Factors Using Electronic Health Records and Natural Language Processing

    Journal of Clinical Medicine, Vol. 11, Núm. 20

2021

  1. Comments on the 2020 ESC/EACTS guidelines for the management of atrial fibrillation

    Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 378-383

  2. Continuity of care and protocols for lipid goals control after an acute coronary syndrome in Spain

    Atencion Primaria, Vol. 53, Núm. 3

  3. Control of LDL-C levels after an acute coronary syndrome in Spain. Are the available treatments adequately used?

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 194-196

2020

  1. Patients' perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists

    Journal of Comparative Effectiveness Research, Vol. 9, Núm. 9, pp. 615-625

  2. Quality of life, medication adherence and satisfaction with anticoagulant treatment (dabigatran vs vitamin K antagonists) according to thromboembolic risk. Data from the CAPANA study

    International Journal of Clinical Practice

2019

  1. Quality of life, adherence and satisfaction of patients with auricular fibrillation treated with dabigatran or vitamin K antagonists

    Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 285-292

2018

  1. Comments on the 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases

    Revista espanola de cardiologia (English ed.), Vol. 71, Núm. 2, pp. 74-78

  2. Programa MICCAP (Manejo de la Insuficiencia Cardiaca en Cardiología y en Atención Primaria): mejorando el manejo del paciente con insuficiencia cardiaca

    Semergen: revista española de medicina de familia, Núm. 8, pp. 572-578

2015

  1. Update for 2014 on clinical cardiology, geriatric cardiology, and heart failure and transplantation

    Revista Espanola de Cardiologia, Vol. 68, Núm. 4, pp. 317-323

2013

  1. Actualización en insuficiencia cardiaca, trasplante cardiaco, cardiopatías congénitas y cardiología clínica

    Revista Espanola de Cardiologia, Vol. 66, Núm. 4, pp. 290-297